Kent Forsén

Summary

Country: Sweden

Publications

  1. ncbi request reprint [Noticeable meta-analysis of atenolol does not cover all aspects]
    Kent Forsén
    Medicinsk marknadskonsult, Molndal
    Lakartidningen 102:61-3. 2005
  2. ncbi request reprint [Criticism against the atenolol meta-analysis remains]
    Kent Forsén
    Lakartidningen 102:412, 414; discussion 414-5. 2005

Detail Information

Publications2

  1. ncbi request reprint [Noticeable meta-analysis of atenolol does not cover all aspects]
    Kent Forsén
    Medicinsk marknadskonsult, Molndal
    Lakartidningen 102:61-3. 2005
  2. ncbi request reprint [Criticism against the atenolol meta-analysis remains]
    Kent Forsén
    Lakartidningen 102:412, 414; discussion 414-5. 2005